Northwestern Medicine Appoints Dr. Wilson Liao to Lead Dermatology Department

Northwestern University Feinberg School of Medicine and Northwestern Memorial HealthCare have announced the appointment of Dr. Wilson Liao as the new chair and Walter J. Hamlin Professor of Dermatology, effective May 1, 2027. Dr. Liao, previously a professor and associate vice chair of research in the Department of Dermatology at the University of California, San Francisco (UCSF), brings a wealth of experience in inflammatory skin disease research, clinical care, and medical education. This appointment signals a continued commitment to advancing dermatological science and patient care at one of the nation's leading academic medical centers.

According to Northwestern University Feinberg School of Medicine, Dr. Liao's new role will encompass overseeing the Department of Dermatology’s clinical, research, and education missions, including its dermatology residency program. His focus will be on fostering the development of the next generation of physician-scientists and clinicians, a critical endeavor for the future of medicine.

Advancing Research in Inflammatory Skin Diseases

Dr. Liao's research is centered on understanding the complex interplay of genetics, immunology, and environmental factors in common inflammatory skin conditions such as psoriasis, atopic dermatitis (eczema), and hidradenitis suppurativa. The Northwestern University Feinberg School of Medicine notes that his work incorporates advanced approaches like machine learning and precision medicine to enhance dermatologic care, aiming to tailor treatments more effectively to individual patient needs. This kind of innovative research is vital for patients living with chronic skin conditions, offering hope for more targeted and personalized therapies.

His extensive publication record, with over 270 peer-reviewed articles on inflammatory skin disease, underscores his significant contributions to the field. He currently directs the UCSF Psoriasis Research Initiative and Biobank, which includes over 1,500 participants, and is a principal investigator for national scientific initiatives such as the National Institutes of Health (NIH) Accelerating Medicine Partnership Program in Autoimmune and Immune-Mediated Diseases (AMP-AIM) and NIH Exposome in Autoimmune Disease Collaborating Teams (EXACT). These initiatives highlight a collaborative approach to unraveling the complexities of autoimmune and immune-mediated diseases, which could have far-reaching implications beyond dermatology.

For students interested in the cutting edge of medical research, understanding these complex diseases often requires a strong foundation in biology, chemistry, and even data science. Free learning platforms like COSMIQ can provide voice-driven AI tutoring to help K-12 students grasp these foundational concepts, making advanced topics like immunology and genetics more accessible. Similarly, students preparing for rigorous exams like AP Biology or chemistry can find valuable resources in COSMIQ's exam prep directory, which covers hundreds of subjects.

A Legacy of Leadership and Innovation

Dr. Liao succeeds Dr. Amy Paller, who served as chair of the department for over 20 years and will transition to the Emeritus Walter J. Hamlin Professor of Dermatology. According to Dr. Eric G. Neilson, vice president for Medical Affairs and Lewis Landsberg Dean, Dr. Paller's tenure was transformative, leading the department to expand significantly in faculty, research scientists, and clinical reach across Northwestern Medicine and Lurie Children’s Hospital. Under her leadership, the department's research enterprise notably climbed in NIH funding rankings, reaching as high as No. 2 in dermatology in 2024, and its residency and research training programs achieved top-tier national recognition.

Dr. Paller's continued involvement in the Department of Dermatology as director of the Skin Biology and Diseases Resource-Based Center, alongside her ongoing clinical practice and research in pediatric and adult skin disorders, genetic and immune-mediated inflammatory conditions, nanotherapy-based gene regulation, and skin barrier biology, ensures that her expertise will continue to benefit Northwestern Medicine. Her work on defining skin and blood biomarkers for pediatric atopic dermatitis and ichthyosis, and developing patient-reported outcome measures for itch and stigma in children, has significantly advanced the understanding and treatment of these conditions.

Impact on Patient Care and Medical Education

The appointment of a leader with Dr. Liao's extensive background in both clinical practice and research is expected to further strengthen Northwestern Medicine's capacity to deliver world-class dermatological care. According to Dr. Howard Chrisman, president and chief executive officer of Northwestern Memorial HealthCare, Dr. Liao's commitment to compassionate care, intellectual curiosity, and driving innovation makes him an ideal choice. His emphasis on physician mentorship and education is also highlighted as a key factor, ensuring that the next generation of dermatologists is well-prepared to tackle complex challenges.

Dr. Liao's experience includes pioneering new dermatology clinical and research programs in Kenya, demonstrating a broader commitment to global health and the dissemination of dermatological knowledge. His co-founding roles in biotechnology and telehealth companies focused on inflammatory skin disease and in-home therapy for psoriasis and eczema also illustrate a dedication to translating research into practical solutions for patients.

Ultimately, this leadership transition at Northwestern University Feinberg School of Medicine is positioned to build upon a strong foundation, aiming to continue fostering advancements in dermatological research, clinical excellence, and the education of future medical professionals, with a direct positive impact on patients suffering from inflammatory skin diseases.